Company Vivos Therapeutics, Inc.

Equities

VVOS

US92859E2072

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:30:01 2024-04-29 pm EDT 5-day change 1st Jan Change
2.59 USD 0.00% Intraday chart for Vivos Therapeutics, Inc. -1.89% -79.18%

Business Summary

Vivos Therapeutics, Inc. is a medical technology company. The Company is focused on the development and commercialization of a suit of diagnostic and multi-disciplinary treatment modalities for patients with cranial and/or dentofacial abnormalities and an array of medical conditions, including mild to moderate obstructive sleep apnea (OSA) and snoring in adults. The Company's Vivos Method is a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities and/or mild to moderate OSA and snoring. The Company's program is to train dentists and offer them other value-added services in connection with their ordering and use of the Vivos System for patients is called the Vivos Integrated Practice program. The Vivos Method comprises of various products and services, such as Vivos Complete Airway Repositioning and/or Expansion (CARE) oral appliance therapy; VivosGuides; Vivos Versa; POD and Night Block, and VivosMyoCorrect.

Number of employees: 119

Sales per Business

USD in Million2022Weight2023Weight Delta
Oral Appliances and Therapeutic Treatments
100.0 %
16 100.0 % 14 100.0 % -13.87%

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
16 100.0 % 14 100.0 % -13.87%

Managers

Managers TitleAgeSince
Founder - 16-07-06
Founder - 16-07-06
Founder - 16-07-06
Chief Executive Officer 66 16-07-06
Director of Finance/CFO 62 18-09-30
Chief Tech/Sci/R&D Officer 51 -
Investor Relations Contact - -
Sales & Marketing - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 19-09-30

Members of the board

Members of the board TitleAgeSince
Director/Board Member 67 20-05-31
Director/Board Member 61 20-05-31
Director/Board Member 56 20-05-31
Director/Board Member 84 20-05-31
Chief Executive Officer 66 16-07-06
Director/Board Member 62 20-05-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 2,982,270 2,529,421 ( 84.82 %) 0 84.82 %

Shareholders

NameEquities%Valuation
Armistice Capital LLC
6.411 %
175,099 6.411 % 845 728 $
Strategic Wealth Designers LLC
4.715 %
128,789 4.715 % 622 051 $
128,788 4.715 % 622 046 $
73,061 2.675 % 352 885 $
Armistice Capital LLC
2.087 %
57,000 2.087 % 275 310 $
Schonfeld Strategic Advisors LLC
1.834 %
50,100 1.834 % 241 983 $
Vanguard Group, Inc. (Subfiler)
0.3873 %
10,579 0.3873 % 51 097 $
Ronald Blue Trust, Inc.
0.1465 %
4,000 0.1465 % 19 320 $
CA Indosuez (Switzerland) SA
0.0866 %
2,365 0.0866 % 11 423 $
Newbridge Financial Services Group, Inc.
0.0714 %
1,950 0.0714 % 9 419 $

Company contact information

Vivos Therapeutics, Inc.

7921 Southpark Plaza Suite 210

80120, Littleton

+

http://www.vivoslife.com
address Vivos Therapeutics, Inc.(VVOS)
  1. Stock Market
  2. Equities
  3. VVOS Stock
  4. Company Vivos Therapeutics, Inc.